Metformin-Pioglitazone Market, Global Outlook and Forecast 2022-2028

March 2022 | 65 pages | ID: M99B731DC9A0EN
Market Monitor Global

Abstracts

Metformin/pioglitazone is used to lower blood sugar levels in type 2 diabetes. It’s used along with diet and exercise.

This report contains market size and forecasts of Metformin-Pioglitazone in Global, including the following market information:

Global Metformin-Pioglitazone Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Metformin-Pioglitazone market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Tablets: 15 mg pioglitazone/1000 mg metformin HCl Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Metformin-Pioglitazone include Takeda Pharmaceuticals, Mylan, Teva, Sandoz, Aurobindo Pharma, MACLEODS and Torrent Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Metformin-Pioglitazone companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Metformin-Pioglitazone Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Metformin-Pioglitazone Market Segment Percentages, by Type, 2021 (%)

• Tablets: 15 mg pioglitazone/1000 mg metformin HCl
• Tablets: 30 mg pioglitazone/1000 mg metformin HCl

Global Metformin-Pioglitazone Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Metformin-Pioglitazone Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Drug store

Global Metformin-Pioglitazone Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Metformin-Pioglitazone Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Metformin-Pioglitazone revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Metformin-Pioglitazone revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Takeda Pharmaceuticals
• Mylan
• Teva
• Sandoz
• Aurobindo Pharma
• MACLEODS
• Torrent Pharmaceuticals

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Metformin-Pioglitazone Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Metformin-Pioglitazone Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL METFORMIN-PIOGLITAZONE OVERALL MARKET SIZE

2.1 Global Metformin-Pioglitazone Market Size: 2021 VS 2028
2.2 Global Metformin-Pioglitazone Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Metformin-Pioglitazone Players in Global Market
3.2 Top Global Metformin-Pioglitazone Companies Ranked by Revenue
3.3 Global Metformin-Pioglitazone Revenue by Companies
3.4 Top 3 and Top 5 Metformin-Pioglitazone Companies in Global Market, by Revenue in 2021
3.5 Global Companies Metformin-Pioglitazone Product Type
3.6 Tier 1, Tier 2 and Tier 3 Metformin-Pioglitazone Players in Global Market
  3.6.1 List of Global Tier 1 Metformin-Pioglitazone Companies
  3.6.2 List of Global Tier 2 and Tier 3 Metformin-Pioglitazone Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Metformin-Pioglitazone Market Size Markets, 2021 & 2028
  4.1.2 Tablets: 15 mg pioglitazone/1000 mg metformin HCl
  4.1.3 Tablets: 30 mg pioglitazone/1000 mg metformin HCl
4.2 By Type - Global Metformin-Pioglitazone Revenue & Forecasts
  4.2.1 By Type - Global Metformin-Pioglitazone Revenue, 2017-2022
  4.2.2 By Type - Global Metformin-Pioglitazone Revenue, 2023-2028
  4.2.3 By Type - Global Metformin-Pioglitazone Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Metformin-Pioglitazone Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Drug store
5.2 By Application - Global Metformin-Pioglitazone Revenue & Forecasts
  5.2.1 By Application - Global Metformin-Pioglitazone Revenue, 2017-2022
  5.2.2 By Application - Global Metformin-Pioglitazone Revenue, 2023-2028
  5.2.3 By Application - Global Metformin-Pioglitazone Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Metformin-Pioglitazone Market Size, 2021 & 2028
6.2 By Region - Global Metformin-Pioglitazone Revenue & Forecasts
  6.2.1 By Region - Global Metformin-Pioglitazone Revenue, 2017-2022
  6.2.2 By Region - Global Metformin-Pioglitazone Revenue, 2023-2028
  6.2.3 By Region - Global Metformin-Pioglitazone Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Metformin-Pioglitazone Revenue, 2017-2028
  6.3.2 US Metformin-Pioglitazone Market Size, 2017-2028
  6.3.3 Canada Metformin-Pioglitazone Market Size, 2017-2028
  6.3.4 Mexico Metformin-Pioglitazone Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Metformin-Pioglitazone Revenue, 2017-2028
  6.4.2 Germany Metformin-Pioglitazone Market Size, 2017-2028
  6.4.3 France Metformin-Pioglitazone Market Size, 2017-2028
  6.4.4 U.K. Metformin-Pioglitazone Market Size, 2017-2028
  6.4.5 Italy Metformin-Pioglitazone Market Size, 2017-2028
  6.4.6 Russia Metformin-Pioglitazone Market Size, 2017-2028
  6.4.7 Nordic Countries Metformin-Pioglitazone Market Size, 2017-2028
  6.4.8 Benelux Metformin-Pioglitazone Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Metformin-Pioglitazone Revenue, 2017-2028
  6.5.2 China Metformin-Pioglitazone Market Size, 2017-2028
  6.5.3 Japan Metformin-Pioglitazone Market Size, 2017-2028
  6.5.4 South Korea Metformin-Pioglitazone Market Size, 2017-2028
  6.5.5 Southeast Asia Metformin-Pioglitazone Market Size, 2017-2028
  6.5.6 India Metformin-Pioglitazone Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Metformin-Pioglitazone Revenue, 2017-2028
  6.6.2 Brazil Metformin-Pioglitazone Market Size, 2017-2028
  6.6.3 Argentina Metformin-Pioglitazone Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Metformin-Pioglitazone Revenue, 2017-2028
  6.7.2 Turkey Metformin-Pioglitazone Market Size, 2017-2028
  6.7.3 Israel Metformin-Pioglitazone Market Size, 2017-2028
  6.7.4 Saudi Arabia Metformin-Pioglitazone Market Size, 2017-2028
  6.7.5 UAE Metformin-Pioglitazone Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Takeda Pharmaceuticals
  7.1.1 Takeda Pharmaceuticals Corporate Summary
  7.1.2 Takeda Pharmaceuticals Business Overview
  7.1.3 Takeda Pharmaceuticals Metformin-Pioglitazone Major Product Offerings
  7.1.4 Takeda Pharmaceuticals Metformin-Pioglitazone Revenue in Global Market (2017-2022)
  7.1.5 Takeda Pharmaceuticals Key News
7.2 Mylan
  7.2.1 Mylan Corporate Summary
  7.2.2 Mylan Business Overview
  7.2.3 Mylan Metformin-Pioglitazone Major Product Offerings
  7.2.4 Mylan Metformin-Pioglitazone Revenue in Global Market (2017-2022)
  7.2.5 Mylan Key News
7.3 Teva
  7.3.1 Teva Corporate Summary
  7.3.2 Teva Business Overview
  7.3.3 Teva Metformin-Pioglitazone Major Product Offerings
  7.3.4 Teva Metformin-Pioglitazone Revenue in Global Market (2017-2022)
  7.3.5 Teva Key News
7.4 Sandoz
  7.4.1 Sandoz Corporate Summary
  7.4.2 Sandoz Business Overview
  7.4.3 Sandoz Metformin-Pioglitazone Major Product Offerings
  7.4.4 Sandoz Metformin-Pioglitazone Revenue in Global Market (2017-2022)
  7.4.5 Sandoz Key News
7.5 Aurobindo Pharma
  7.5.1 Aurobindo Pharma Corporate Summary
  7.5.2 Aurobindo Pharma Business Overview
  7.5.3 Aurobindo Pharma Metformin-Pioglitazone Major Product Offerings
  7.5.4 Aurobindo Pharma Metformin-Pioglitazone Revenue in Global Market (2017-2022)
  7.5.5 Aurobindo Pharma Key News
7.6 MACLEODS
  7.6.1 MACLEODS Corporate Summary
  7.6.2 MACLEODS Business Overview
  7.6.3 MACLEODS Metformin-Pioglitazone Major Product Offerings
  7.6.4 MACLEODS Metformin-Pioglitazone Revenue in Global Market (2017-2022)
  7.6.5 MACLEODS Key News
7.7 Torrent Pharmaceuticals
  7.7.1 Torrent Pharmaceuticals Corporate Summary
  7.7.2 Torrent Pharmaceuticals Business Overview
  7.7.3 Torrent Pharmaceuticals Metformin-Pioglitazone Major Product Offerings
  7.7.4 Torrent Pharmaceuticals Metformin-Pioglitazone Revenue in Global Market (2017-2022)
  7.7.5 Torrent Pharmaceuticals Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Metformin-Pioglitazone Market Opportunities & Trends in Global Market
Table 2. Metformin-Pioglitazone Market Drivers in Global Market
Table 3. Metformin-Pioglitazone Market Restraints in Global Market
Table 4. Key Players of Metformin-Pioglitazone in Global Market
Table 5. Top Metformin-Pioglitazone Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Metformin-Pioglitazone Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Metformin-Pioglitazone Revenue Share by Companies, 2017-2022
Table 8. Global Companies Metformin-Pioglitazone Product Type
Table 9. List of Global Tier 1 Metformin-Pioglitazone Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Metformin-Pioglitazone Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Metformin-Pioglitazone Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Metformin-Pioglitazone Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Metformin-Pioglitazone Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Metformin-Pioglitazone Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Metformin-Pioglitazone Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Metformin-Pioglitazone Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Metformin-Pioglitazone Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Metformin-Pioglitazone Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Metformin-Pioglitazone Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Metformin-Pioglitazone Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Metformin-Pioglitazone Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Metformin-Pioglitazone Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Metformin-Pioglitazone Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Metformin-Pioglitazone Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Metformin-Pioglitazone Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Metformin-Pioglitazone Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Metformin-Pioglitazone Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Metformin-Pioglitazone Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Metformin-Pioglitazone Revenue, (US$, Mn), 2023-2028
Table 30. Takeda Pharmaceuticals Corporate Summary
Table 31. Takeda Pharmaceuticals Metformin-Pioglitazone Product Offerings
Table 32. Takeda Pharmaceuticals Metformin-Pioglitazone Revenue (US$, Mn), (2017-2022)
Table 33. Mylan Corporate Summary
Table 34. Mylan Metformin-Pioglitazone Product Offerings
Table 35. Mylan Metformin-Pioglitazone Revenue (US$, Mn), (2017-2022)
Table 36. Teva Corporate Summary
Table 37. Teva Metformin-Pioglitazone Product Offerings
Table 38. Teva Metformin-Pioglitazone Revenue (US$, Mn), (2017-2022)
Table 39. Sandoz Corporate Summary
Table 40. Sandoz Metformin-Pioglitazone Product Offerings
Table 41. Sandoz Metformin-Pioglitazone Revenue (US$, Mn), (2017-2022)
Table 42. Aurobindo Pharma Corporate Summary
Table 43. Aurobindo Pharma Metformin-Pioglitazone Product Offerings
Table 44. Aurobindo Pharma Metformin-Pioglitazone Revenue (US$, Mn), (2017-2022)
Table 45. MACLEODS Corporate Summary
Table 46. MACLEODS Metformin-Pioglitazone Product Offerings
Table 47. MACLEODS Metformin-Pioglitazone Revenue (US$, Mn), (2017-2022)
Table 48. Torrent Pharmaceuticals Corporate Summary
Table 49. Torrent Pharmaceuticals Metformin-Pioglitazone Product Offerings
Table 50. Torrent Pharmaceuticals Metformin-Pioglitazone Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Metformin-Pioglitazone Segment by Type in 2021
Figure 2. Metformin-Pioglitazone Segment by Application in 2021
Figure 3. Global Metformin-Pioglitazone Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Metformin-Pioglitazone Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Metformin-Pioglitazone Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Metformin-Pioglitazone Revenue in 2021
Figure 8. By Type - Global Metformin-Pioglitazone Revenue Market Share, 2017-2028
Figure 9. By Application - Global Metformin-Pioglitazone Revenue Market Share, 2017-2028
Figure 10. By Region - Global Metformin-Pioglitazone Revenue Market Share, 2017-2028
Figure 11. By Country - North America Metformin-Pioglitazone Revenue Market Share, 2017-2028
Figure 12. US Metformin-Pioglitazone Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Metformin-Pioglitazone Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Metformin-Pioglitazone Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Metformin-Pioglitazone Revenue Market Share, 2017-2028
Figure 16. Germany Metformin-Pioglitazone Revenue, (US$, Mn), 2017-2028
Figure 17. France Metformin-Pioglitazone Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Metformin-Pioglitazone Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Metformin-Pioglitazone Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Metformin-Pioglitazone Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Metformin-Pioglitazone Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Metformin-Pioglitazone Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Metformin-Pioglitazone Revenue Market Share, 2017-2028
Figure 24. China Metformin-Pioglitazone Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Metformin-Pioglitazone Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Metformin-Pioglitazone Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Metformin-Pioglitazone Revenue, (US$, Mn), 2017-2028
Figure 28. India Metformin-Pioglitazone Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Metformin-Pioglitazone Revenue Market Share, 2017-2028
Figure 30. Brazil Metformin-Pioglitazone Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Metformin-Pioglitazone Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Metformin-Pioglitazone Revenue Market Share, 2017-2028
Figure 33. Turkey Metformin-Pioglitazone Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Metformin-Pioglitazone Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Metformin-Pioglitazone Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Metformin-Pioglitazone Revenue, (US$, Mn), 2017-2028
Figure 37. Takeda Pharmaceuticals Metformin-Pioglitazone Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Mylan Metformin-Pioglitazone Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Teva Metformin-Pioglitazone Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Sandoz Metformin-Pioglitazone Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Aurobindo Pharma Metformin-Pioglitazone Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. MACLEODS Metformin-Pioglitazone Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Torrent Pharmaceuticals Metformin-Pioglitazone Revenue Year Over Year Growth (US$, Mn) & (2017-2022)